Yes: Rituximab (rituxin) is a monoclonal antibody to cd20 an antigen located on lymphocytes. One consequence of using this drug is a drop in lymphocyte numbers (bad cells and good cells). This decline lowers the effectiveness of the immune system for a period of time.
Answered 1/16/2021
5.7k views
Yes: Rituximab is directed against an antigen found on lymphocytes (cd20). It attaches to this antigen and causes destruction of the lymphocyte. Its action is indiscriminate therefore the lymphocyte population is transiently decreased leading to a lowering of the function of the immune system for brief periods of time.
Answered 3/23/2020
5.7k views
3 doctors weighed in across 2 answers
3 doctors weighed in across 2 answers
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question